Melanotan-2
MT-II, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
Synthetic analogue of α-MSH that stimulates melanogenesis for skin tanning and may increase sexual arousal.
Suspended
PHASE3
NCT03811015
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT03839940
Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
Alliance for Clinical Trials in Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1, PHASE2
NCT00325416
Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.
H. Lee Moffitt Cancer Center and Research Institute
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT04410991
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)
Sanofi
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00337168
S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Enrolling By Invitation
NA
NCT07072104
Reading-FREE Markers for Early Detection of Developmental Dyslexia
Università Vita-Salute San Raffaele
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE2, PHASE3
NCT02065687
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
Gynecologic Oncology Group
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT04882098
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Janssen Research & Development, LLC
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE2
NCT00334815
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT04251052
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NRG Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT04939428
Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)
Merck Sharp & Dohme LLC
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT03671681
Mindfulness Therapy for Chronic Migraine
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT04612244
The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation
Boston Scientific Corporation
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT05561387
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE2
NCT00658814
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE1, PHASE2
NCT03311334
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors
Sumitomo Pharma America, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT00625898
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
NSABP Foundation Inc
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT04224493
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
Epizyme, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00046371
Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients
Oncothyreon Canada Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00433381
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025